Pharmacist Resources
Key Points for Pharmacists
- The pharmacy certifies with Lenalidomide REMS
- The certified pharmacy must obtain a confirmation number from Lenalidomide REMS before dispensing
- The certified pharmacy counsels the patient, and completes the Education and Counseling Checklist
- The certified pharmacy dispenses lenalidomide to patient along with a Medication Guide
Lenalidomide REMS information for certified pharmacies
Lenalidomide is only dispensed from Lenalidomide REMS certified pharmacies.
As a Lenalidomide REMS certified pharmacy, you must follow the requirements of Lenalidomide REMS. You may download a guide to the program, a checklist for counseling patients, and the full prescribing information below.
Pharmacy Guide to
Lenalidomide REMS
Education and Counseling
Checklist for Pharmacies
Lista de verificación de educación
y asesoramiento para farmacias
Pharmacy Portal for Celgene-administered REMS Programs
In addition to calling Lenalidomide REMS to obtain a confirmation number for a prescription, eligible pharmacies can obtain confirmation numbers using the Pharmacy Portal for Celgene-administered REMS Programs at CelgeneREMSPharmacyPortal.com. Contact Lenalidomide REMS to see if your pharmacy is eligible.
Please report adverse drug experiences that are suspected to be associated with the use of lenalidomide and any suspected pregnancy occurring during the treatment with lenalidomide using any of the following methods:
| REPORTING TO Lenalidomide REMS | |
| Online: | www.celgene.com/contact-us/ |
| Email: | drugsafety@celgene.com |
| Telephone: | 1-908-673-9667 |
| Toll-free: | 1-800-640-7854 (Global Drug Safety & Risk Management) or 1-888-423-5436 (Lenalidomide REMS) |
| Fax: | 1-908-673-9115 |
| Mail to: | Global Drug Safety & Risk Management Celgene Corporation 86 Morris Avenue Summit, New Jersey 07901 |
| REPORTING TO THE FDA |
|
| Adverse drug experiences that are suspected to be associated with the use of lenalidomide and any suspected pregnancy occurring during the treatment with lenalidomide may also be reported to the FDA MedWatch Reporting System using any of the following methods: |
|
| Online: | https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm |
| Telephone: | 1-800-FDA-1088 |
| Fax: | 1-800-FDA-0178 |
| Mail to: | MedWatch 5600 Fishers Lane Rockville, MD 20852-9787 |
